DVA – DaVita Inc.
DaVita Inc.DVA
$142.31Name : DaVita Inc.
Sector : Healthcare
Industry: Medical Care Facilities
Mark. Cap: $10,754,983,936.00
EPSttm : 10.09
DaVita Inc.
$142.31
0.45%$0.635Float Short %
8.64
Margin Of Safety %
1
Put/Call OI Ratio
1.73
EPS Next Q Diff
1.22
EPS Last/This Y
-0.31
EPS This/Next Y
1.92
Price
141.73
Target Price
162.29
Analyst Recom
2.83
Performance Q
-7.1
Relative Volume
1.39
Beta
1.11
Ticker: DVA
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-06-02 | DVA | 134.45 | 1.20 | 1.04 | 32122 |
| 2025-06-03 | DVA | 136 | 1.18 | 0.53 | 32480 |
| 2025-06-04 | DVA | 136.78 | 1.17 | 0.80 | 32636 |
| 2025-06-05 | DVA | 137.76 | 1.17 | 0.91 | 32761 |
| 2025-06-06 | DVA | 137.89 | 1.16 | 1.15 | 32802 |
| 2025-06-09 | DVA | 137.77 | 1.16 | 0.10 | 32866 |
| 2025-06-10 | DVA | 139.07 | 1.16 | 0.69 | 32933 |
| 2025-06-11 | DVA | 138.17 | 1.16 | 0.06 | 32991 |
| 2025-06-12 | DVA | 137.28 | 1.14 | 1.50 | 33326 |
| 2025-06-13 | DVA | 136.03 | 1.13 | 0.08 | 33298 |
| 2025-06-16 | DVA | 137.83 | 1.13 | 0.64 | 33480 |
| 2025-06-17 | DVA | 136.55 | 1.12 | 4.34 | 33825 |
| 2025-06-18 | DVA | 135.69 | 1.12 | 2.04 | 33832 |
| 2025-06-20 | DVA | 136.93 | 1.12 | 1.45 | 33934 |
| 2025-06-23 | DVA | 136.34 | 1.79 | 0.15 | 23017 |
| 2025-06-24 | DVA | 141 | 1.76 | 0.67 | 23233 |
| 2025-06-25 | DVA | 140.45 | 1.74 | 1.57 | 23336 |
| 2025-06-26 | DVA | 141.03 | 1.73 | 0.95 | 23434 |
| 2025-06-27 | DVA | 141.72 | 1.73 | 0.03 | 23582 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-06-02 | DVA | 134.44 | 6.6 | 23.1 | 10.93 |
| 2025-06-03 | DVA | 135.99 | 6.6 | 46.3 | 10.93 |
| 2025-06-04 | DVA | 136.77 | 6.6 | 40.7 | 10.93 |
| 2025-06-05 | DVA | 137.74 | 6.6 | 42.2 | 10.93 |
| 2025-06-06 | DVA | 137.88 | 6.6 | 36.3 | 10.93 |
| 2025-06-09 | DVA | 137.78 | 6.6 | 34.7 | 10.93 |
| 2025-06-10 | DVA | 139.13 | 6.6 | 44.5 | 10.93 |
| 2025-06-11 | DVA | 138.14 | 6.6 | 28.9 | 10.93 |
| 2025-06-12 | DVA | 137.35 | 6.6 | 29.9 | 10.93 |
| 2025-06-13 | DVA | 136.07 | 6.6 | 26.8 | 10.93 |
| 2025-06-16 | DVA | 137.83 | 6.5 | 47.1 | 10.87 |
| 2025-06-17 | DVA | 136.54 | 6.5 | 26.7 | 10.87 |
| 2025-06-18 | DVA | 135.79 | 6.5 | 30.6 | 10.87 |
| 2025-06-20 | DVA | 136.94 | 6.5 | 43.3 | 10.71 |
| 2025-06-23 | DVA | 136.28 | 6.5 | 31.0 | 10.71 |
| 2025-06-24 | DVA | 140.91 | 6.5 | 66.5 | 10.71 |
| 2025-06-25 | DVA | 140.37 | 6.5 | 31.5 | 10.71 |
| 2025-06-26 | DVA | 141.00 | 6.5 | 39.7 | 10.71 |
| 2025-06-27 | DVA | 141.73 | 6.5 | 39.7 | 10.71 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-06-02 | DVA | -38.47 | -3.82 | 7.70 |
| 2025-06-03 | DVA | -38.47 | -3.82 | 7.70 |
| 2025-06-04 | DVA | -38.47 | -3.82 | 7.70 |
| 2025-06-05 | DVA | -38.47 | -3.82 | 7.70 |
| 2025-06-06 | DVA | -38.47 | -3.82 | 7.70 |
| 2025-06-09 | DVA | -38.47 | -3.82 | 7.70 |
| 2025-06-10 | DVA | -38.47 | -3.82 | 7.70 |
| 2025-06-11 | DVA | -38.47 | -3.82 | 8.14 |
| 2025-06-12 | DVA | -38.47 | -3.82 | 8.14 |
| 2025-06-13 | DVA | -38.47 | -3.82 | 8.14 |
| 2025-06-16 | DVA | -38.47 | -3.77 | 8.14 |
| 2025-06-17 | DVA | -38.47 | -3.77 | 8.14 |
| 2025-06-18 | DVA | -38.47 | -3.77 | 8.14 |
| 2025-06-20 | DVA | -38.47 | -3.77 | 8.14 |
| 2025-06-23 | DVA | -38.47 | -3.78 | 8.14 |
| 2025-06-24 | DVA | -38.47 | -3.78 | 8.14 |
| 2025-06-25 | DVA | -38.47 | -3.78 | 8.14 |
| 2025-06-26 | DVA | -38.47 | -3.78 | 8.64 |
| 2025-06-27 | DVA | -38.47 | -3.78 | 8.64 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
2
Avg. EPS Est. Current Quarter
2.76
Avg. EPS Est. Next Quarter
3.22
Insider Transactions
-38.47
Institutional Transactions
-3.78
Beta
1.11
Average Sales Estimate Current Quarter
3363
Average Sales Estimate Next Quarter
3442
Fair Value
143.05
Quality Score
65
Growth Score
78
Sentiment Score
61
Actual DrawDown %
21.1
Max Drawdown 5-Year %
-51.1
Target Price
162.29
P/E
14.02
Forward P/E
11.18
PEG
0.94
P/S
0.82
P/B
P/Free Cash Flow
6.06
EPS
10.1
Average EPS Est. Cur. Y
10.71
EPS Next Y. (Est.)
12.63
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
6.63
Relative Volume
1.39
Return on Equity vs Sector %
-345.7
Return on Equity vs Industry %
-376.7
EPS 1 7Days Diff
-0.2
EPS 1 30Days Diff
-0.29
EBIT Estimation
39.7
DaVita Inc.Sector: Healthcare
Industry: Medical Care Facilities
Employees: 76000
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
stock quote shares DVA – DaVita Inc. Stock Price stock today
news today DVA – DaVita Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch DVA – DaVita Inc. yahoo finance google finance
stock history DVA – DaVita Inc. invest stock market
stock prices DVA premarket after hours
ticker DVA fair value insiders trading